The Cost Of Drug-Related Morbidity
That Lead To Emergency Visits In A
Brazilian Hospital
Freitas G.1, Tramontina M.Y.1, Balbinotto
G.1, Hughes D.2, Heineck I.1
1Federal University of Rio Grande do Sul, Porto Alegre, Brazil,
2Bangor University, Bangor, UK
Introduction
• Pharmacotherapy
when it fails and does not achieve optimal results or minimally
expected effect, the problems are described with differentexpected effect, the problems are described with different
terms:
– adverse drug events (ADEs),
– drug related problems (DRP),
– adverse drug reactions (ADRs),
– drug related morbidity (DRM).
Introduction
• 5% to 25% of all hospitalizations and more than 12% of visits
to emergency services are related to drugs
• 50% to 70% of cases are preventable
Zed PJ et al. The Journal of Pediatrics. 2013;163(2):477-83
Introduction
• DRPs include 28% of emergency cases
– 24% result in hospital admission
• 4/10 emergency medical services do not associate these visits
Patel P & Zed PJ. Pharmacotherapy. 2012;22: 915–923
• 4/10 emergency medical services do not associate these visits
to drug related morbidity
– Patients are inappropriately managed
Hohl CM et al. Annals of Emergency Medicine. 2010;55:493-502
Introduction
• For each US$ 1.00 spent on drugs, US$ 1.33 spent to treat
problems related to drugs
• According to the World Health Organization, 50% of all
medicines are prescribed, dispensed or used inappropriately
Johnson JA & Bootman JL: Arch Intern Med 1995, 155:1949-1956.
medicines are prescribed, dispensed or used inappropriately
• The cost of drugs related morbidity and mortality was
estimated at US$289 billion in the United States.
New England Healthcare Institute (NEHI). Thinking Outside the Pillbox: A
Systemwide Approach to Improving Patient Medication Adherence for Chronic
Disease. 2009.
Aim
• The aim of this work is to estimate the cost of managing
health problems related to drugs that lead to visits to the
emergency department of a large teaching hospital inemergency department of a large teaching hospital in
southern Brazil.
Methods
• Cross- sectional study.
• Data collection: medical records and interview.
• From all patients that sought emergency services over a six-
month period in a large teaching hospital in Brazil, 535 were
interviewed and those with DRM were identified using ainterviewed and those with DRM were identified using a
validated questionnaire
• Micro-costing analysis
• Sensitivity analysis (emergency room visits rates due to DRM
reported in the literature)
• All costs are presented in 2014 US$ (US$1=R$2.70)
Results
• 14.6% of patients sought emergency care due to DRM
– 58.9% of DRMs were considered preventable
• Mean treatment costs were US$812.38 ± 1,417 (range
US$16.04 to 9,832)US$16.04 to 9,832)
• Mean inpatient length of stay of DRM patients was 5.7 ± 8.4
days
Results
• Dividing the total expense for the causes of DRM:
16,9%
6,9%
36,9%
Non-adherence
ADR
Incorrect dose
Others
39,3%
Results
• Annual total treatment costs of US$6.773 million.
• Sensitivity analysis
– US$1.043 million in the best-case scenario
– US$12.989 milion at worst, per year– US$12.989 milion at worst, per year
% of patients that look for emergency
service because of DRM*
Best case scenario
(2.25%)
Worst case
scenario (28.1%)
Rodríguez-Monguió R, Otero MJ, Rovira J.Assessing the economic impact of
adverse drug effects. Pharmacoeconomics. 2003;21(9):623-50.
Conclusion
• DRM that leads to the search for emergency services are
frequent and generate a significant economic impact to the
hospital.
• The estimated annual cost for treating these patients is• The estimated annual cost for treating these patients is
around US$ 6.7 million, ranging from US$ 1.1 million to US$
13 million
• Much of this resource is spent to treat preventable cases of
DRM, which represents a great waste of resources.
Conclusion
• Adverse drug reactions and the non-adherence to treatment
are important causes of morbidity and cost to the health
service.
• Educating patients about the correct use of their medications,
identify possible adverse events and to monitor therapeutic
outcomes could reduce queues in emergencies,
hospitalizations , absenteeism and consequently costs for the
hospital, the health system and society.
grmf.pharma@gmail.com

HTAi 2015 - The Cost of Drugs Related Morbidity that lead to emergency visit ina a Brazilian Hospital.

  • 1.
    The Cost OfDrug-Related Morbidity That Lead To Emergency Visits In A Brazilian Hospital Freitas G.1, Tramontina M.Y.1, Balbinotto G.1, Hughes D.2, Heineck I.1 1Federal University of Rio Grande do Sul, Porto Alegre, Brazil, 2Bangor University, Bangor, UK
  • 2.
    Introduction • Pharmacotherapy when itfails and does not achieve optimal results or minimally expected effect, the problems are described with differentexpected effect, the problems are described with different terms: – adverse drug events (ADEs), – drug related problems (DRP), – adverse drug reactions (ADRs), – drug related morbidity (DRM).
  • 3.
    Introduction • 5% to25% of all hospitalizations and more than 12% of visits to emergency services are related to drugs • 50% to 70% of cases are preventable Zed PJ et al. The Journal of Pediatrics. 2013;163(2):477-83
  • 4.
    Introduction • DRPs include28% of emergency cases – 24% result in hospital admission • 4/10 emergency medical services do not associate these visits Patel P & Zed PJ. Pharmacotherapy. 2012;22: 915–923 • 4/10 emergency medical services do not associate these visits to drug related morbidity – Patients are inappropriately managed Hohl CM et al. Annals of Emergency Medicine. 2010;55:493-502
  • 5.
    Introduction • For eachUS$ 1.00 spent on drugs, US$ 1.33 spent to treat problems related to drugs • According to the World Health Organization, 50% of all medicines are prescribed, dispensed or used inappropriately Johnson JA & Bootman JL: Arch Intern Med 1995, 155:1949-1956. medicines are prescribed, dispensed or used inappropriately • The cost of drugs related morbidity and mortality was estimated at US$289 billion in the United States. New England Healthcare Institute (NEHI). Thinking Outside the Pillbox: A Systemwide Approach to Improving Patient Medication Adherence for Chronic Disease. 2009.
  • 6.
    Aim • The aimof this work is to estimate the cost of managing health problems related to drugs that lead to visits to the emergency department of a large teaching hospital inemergency department of a large teaching hospital in southern Brazil.
  • 7.
    Methods • Cross- sectionalstudy. • Data collection: medical records and interview. • From all patients that sought emergency services over a six- month period in a large teaching hospital in Brazil, 535 were interviewed and those with DRM were identified using ainterviewed and those with DRM were identified using a validated questionnaire • Micro-costing analysis • Sensitivity analysis (emergency room visits rates due to DRM reported in the literature) • All costs are presented in 2014 US$ (US$1=R$2.70)
  • 8.
    Results • 14.6% ofpatients sought emergency care due to DRM – 58.9% of DRMs were considered preventable • Mean treatment costs were US$812.38 ± 1,417 (range US$16.04 to 9,832)US$16.04 to 9,832) • Mean inpatient length of stay of DRM patients was 5.7 ± 8.4 days
  • 9.
    Results • Dividing thetotal expense for the causes of DRM: 16,9% 6,9% 36,9% Non-adherence ADR Incorrect dose Others 39,3%
  • 10.
    Results • Annual totaltreatment costs of US$6.773 million. • Sensitivity analysis – US$1.043 million in the best-case scenario – US$12.989 milion at worst, per year– US$12.989 milion at worst, per year % of patients that look for emergency service because of DRM* Best case scenario (2.25%) Worst case scenario (28.1%) Rodríguez-Monguió R, Otero MJ, Rovira J.Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21(9):623-50.
  • 11.
    Conclusion • DRM thatleads to the search for emergency services are frequent and generate a significant economic impact to the hospital. • The estimated annual cost for treating these patients is• The estimated annual cost for treating these patients is around US$ 6.7 million, ranging from US$ 1.1 million to US$ 13 million • Much of this resource is spent to treat preventable cases of DRM, which represents a great waste of resources.
  • 12.
    Conclusion • Adverse drugreactions and the non-adherence to treatment are important causes of morbidity and cost to the health service. • Educating patients about the correct use of their medications, identify possible adverse events and to monitor therapeutic outcomes could reduce queues in emergencies, hospitalizations , absenteeism and consequently costs for the hospital, the health system and society.
  • 13.